I had to hunt high and low but I found something.
This piece really has everything a little Fisher & Paykel holder really wants to know.
What he neglects to tell us is, has Mike Daniells passed all his business acumen on.
I would have to answer that by saying yes by looking at the figures, 29-800 million, in 26 years.
What is more important is, has he passed that "we are a company that is going to spend northwards of 70 million next year on R & D" and you would have to say yes again.
Lewis Gradon is still there as head of R & D and as long as he is I don't have one worry.
Share Investor's 2012 Stock Picks
Global Market Sell-Off Stocks: Fisher & Paykel Healthcare
Resmed takes market share from Fisher & Paykel Healthcare
Resmed kicking Fisher & Paykel Heathcares butt?
Share Price Alert: Fisher & Paykel Healthcare Ltd
I'm Buying: Fisher & Paykel Healthcare Ltd
Share Investor's Total Returns: Fisher & Paykel Healthcare Ltd
Share Investor's 2011 Stock Picks
Stock of the Week: Fisher & Paykel Healthcare Ltd
Fisher & Paykel Healthcare & the US Dollar
Mondrian Investment Partners take stake in Fisher & Paykel Healthcare
Fisher & Paykel Healthcare: 2010 Full Year Profit rests on Foreign exchange movement
Long Term View: Fisher & Paykel Healthcare
Stock of the Week: Fisher & Paykel Healthcare
Analysis - Fisher & Paykel Healthcare: FY Profit to 31/03/09
Schroder Investment Management takes big Fisher & Paykel Healthcare stake
Long VS Short: Fisher & Paykel Healthcare
Big Fisher & Paykel Healthcare trades a curious taleWhy did you buy that stock? [Fisher & Paykel Healthcare]
Drinking and Trading
Share Investor's 2008 stock picks
Fisher & Paykel: A tale of two companies
FPH downgrade masks good performance
Discuss FPH @ Share Investor Forum
Download FPH Company Reports
Project Management Essentials For Dummies, Australian and New Zealand Edition by Nick Graham Buy new: $9.74 / Used from: $8.96 Usually ships in 24 hours |